Published in Br J Pharmacol on June 19, 2006
Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor. J Neurosci (2010) 1.29
Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons. Br J Pharmacol (2012) 1.24
How to design an opioid drug that causes reduced tolerance and dependence. Ann Neurol (2010) 1.09
Endogenous opiates and behavior: 2006. Peptides (2007) 0.92
Let-7 microRNAs and Opioid Tolerance. Front Genet (2012) 0.90
Morphine- and CaMKII-dependent enhancement of GIRK channel signaling in hippocampal neurons. J Neurosci (2010) 0.88
β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons. Br J Pharmacol (2014) 0.80
Analgesic tolerance to morphine is regulated by PPARγ. Br J Pharmacol (2014) 0.79
Effects of receptor density on Nociceptin/OrphaninFQ peptide receptor desensitisation: studies using the ecdysone inducible expression system. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.77
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch (1981) 134.60
Quantitative real-time RT-PCR--a perspective. J Mol Endocrinol (2005) 6.72
Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev (2001) 3.45
Roles of tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neurons. J Neurosci (2002) 2.71
Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat Neurosci (1999) 1.94
Antinociceptive and nociceptive actions of opioids. J Neurobiol (2004) 1.93
Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol (2005) 1.82
Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol Pharmacol (1987) 1.80
Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375. EMBO J (2004) 1.77
Opioids in pain management. Lancet (1999) 1.69
Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. J Neurosci (2002) 1.58
Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J Neurosci (1998) 1.54
Role of NK-1 neurotransmission in opioid-induced hyperalgesia. Pain (2005) 1.49
Morphine and pain-related stimuli enhance cell surface availability of somatic delta-opioid receptors in rat dorsal root ganglia. J Neurosci (2006) 1.43
Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci (2001) 1.30
Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine. Br J Pharmacol (2005) 1.16
Characterization of potassium currents in adult rat sensory neurons and modulation by opioids and cyclic AMP. Neuroscience (1993) 1.15
Opioid agonists differentially regulate mu-opioid receptors and trafficking proteins in vivo. Mol Pharmacol (2002) 1.15
GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal. Neuron (2005) 1.15
Continued morphine modulation of calcium channel currents in acutely isolated locus coeruleus neurons from morphine-dependent rats. Br J Pharmacol (1999) 1.13
Chronic exposure to morphine does not induce dependence at the level of the calcium channel current in human SH-SY5Y cells. Neuroscience (1992) 1.12
Resting and evoked spinal substance P release during chronic intrathecal morphine infusion: parallels with tolerance and dependence. J Pharmacol Exp Ther (2005) 1.11
Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. Br J Pharmacol (2002) 1.11
Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse. J Physiol (2001) 1.10
A calcitonin gene-related peptide receptor antagonist prevents the development of tolerance to spinal morphine analgesia. J Neurosci (1996) 1.07
Age-dependent opioid escalation in chronic pain patients. Anesth Analg (2005) 1.05
How do G proteins directly control neuronal Ca2+ channel function? Trends Pharmacol Sci (2005) 1.03
Chronic morphine administration increases beta-adrenergic receptor kinase (beta ARK) levels in the rat locus coeruleus. J Neurochem (1994) 1.02
The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment. Neurosignals (2005) 1.01
The orofacial capsaicin test in rats: effects of different capsaicin concentrations and morphine. Pain (2002) 1.00
Peripheral morphine analgesia in dental surgery. Pain (1998) 0.98
Prostaglandin E(2) inhibits calcium current in two sub-populations of acutely isolated mouse trigeminal sensory neurons. J Physiol (2002) 0.96
Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation. Clin Pharmacol Ther (2001) 0.95
Opioid inhibition and desensitization of calcium channel currents in rat dorsal root ganglion neurons. J Pharmacol Exp Ther (1994) 0.94
Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br J Pharmacol (1999) 0.93
Continuous administration of the 5-hydroxytryptamine1A agonist (3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-[[(5-methyl-pyridin-2-ylmethyl) -amino]-methyl]piperidin-1-yl]-methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain. J Pharmacol Exp Ther (2003) 0.91
Mu-opioid receptor inhibition of calcium current: development of homologous tolerance in single SH-SY5Y cells after chronic exposure to morphine in vitro. Mol Pharmacol (1991) 0.87
Functional compartmentalization of opioid desensitization in primary sensory neurons. J Pharmacol Exp Ther (2000) 0.87
The peripheral antinociceptive effect of morphine in a rat model of facial pain. Neuroscience (1996) 0.87
RGS proteins: new players in the field of opioid signaling and tolerance mechanisms. Anesth Analg (2005) 0.86
Inhibition of morphine tolerance by spinal melanocortin receptor blockade. Pain (2005) 0.85
Chronic morphine induces tolerance and desensitization of mu-opioid receptor but not down-regulation in rabbit. Eur J Pharmacol (1994) 0.83
Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS. Psychopharmacology (Berl) (2005) 0.81
Mu-opioid receptor mRNA regulation during morphine tolerance in the rat peripheral nervous system. Anesth Analg (2003) 0.80
Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol (2005) 1.82
Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors. J Biol Chem (2003) 1.78
Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J Physiol (2002) 1.29
Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine. Br J Pharmacol (2005) 1.16
The thalamostriatal pathway and cholinergic control of goal-directed action: interlacing new with existing learning in the striatum. Neuron (2013) 1.14
Gingerols: a novel class of vanilloid receptor (VR1) agonists. Br J Pharmacol (2002) 1.11
Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. Br J Pharmacol (2002) 1.11
Cellular morphine tolerance produced by βarrestin-2-dependent impairment of μ-opioid receptor resensitization. J Neurosci (2011) 1.09
The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment. Neurosignals (2005) 1.01
Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine. Br J Pharmacol (2009) 1.01
Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol. J Biol Chem (2008) 1.00
Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action. Br J Pharmacol (2013) 0.97
Prostaglandin E(2) inhibits calcium current in two sub-populations of acutely isolated mouse trigeminal sensory neurons. J Physiol (2002) 0.96
A continuous, fluorescence-based assay of μ-opioid receptor activation in AtT-20 cells. J Biomol Screen (2012) 0.89
TRPV1 antagonists as a potential treatment for hyperalgesia. Recent Pat CNS Drug Discov (2006) 0.87
Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Mol Pain (2008) 0.86
Expression of mRNA and functional alpha(1)-adrenoceptors that suppress the GIRK conductance in adult rat locus coeruleus neurons. Br J Pharmacol (2002) 0.85
The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse. ACS Chem Neurosci (2013) 0.84
Methanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitro. Neuropharmacology (2007) 0.81
Pharmacological characterization of a recombinant, fluorescent somatostatin receptor agonist. Bioconjug Chem (2011) 0.81
Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1). Br J Pharmacol (2014) 0.81
Lack of functional expression of NMDA receptors in PC12 cells. Neurotoxicology (2007) 0.81
A real-time, fluorescence-based assay for measuring μ-opioid receptor modulation of adenylyl cyclase activity in Chinese hamster ovary cells. J Biomol Screen (2013) 0.80
Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HT. Br J Pharmacol (2012) 0.79
Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro. Br J Pharmacol (2014) 0.78
The results of an experimental indoor hydroponic Cannabis growing study, using the 'Screen of Green' (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis. Forensic Sci Int (2010) 0.78
Convulsant actions of calycanthine. Toxicol Appl Pharmacol (2003) 0.77
Targeting somatostatin receptors using in situ-bioconjugated fluorescent nanoparticles. Nanomedicine (Lond) (2012) 0.77
A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro. Br J Pharmacol (2015) 0.75
Fluorescence-based, high-throughput assays for μ-opioid receptor activation using a membrane potential-sensitive dye. Methods Mol Biol (2015) 0.75
Development of Bright and Biocompatible Nanoruby and its Application to Background-free Time-gated Imaging of G-protein Coupled Receptors. ACS Appl Mater Interfaces (2017) 0.75